Physician-led · Technology-driven · 5 Global offices
Elite clinical research.
Intelligently delivered.
iNGENū is a full-service, physician-led CRO delivering the scientific rigour and regulatory precision of a top-tier US clinical research organisation — underpinned by proprietary in-house technology and priced for the way clinical trials should work.
✓
Physician-owned
5
Global offices
40+
Studies in progress
80–90%
Below US CRO costs
Industry recognition
Frost & Sullivan 2026 Asia-Pacific Biotech CRO Customer Value Leadership Award
Recognised for reimagining the CRO model through physician-led engagement, proprietary technology, and an integrated clinical architecture that transforms trial execution across the Asia-Pacific region.
The iNGENū difference
Full-service capability. Purpose-built technology. Physician-grade oversight.
iNGENū was engineered from inception as a fully integrated, technology-native clinical research organisation. Every workflow, quality system, and reporting pipeline has been architected around proprietary in-house technology — with real-time reporting, risk-based quality management, continuous self-audited quality systems, and a fully integrated eClinical suite — with physician oversight at every clinical decision point.
The result is a CRO that delivers the depth of capability sponsors expect from the largest global organisations — with the precision, speed, and cost discipline that only a physician-owned, technology-first model can achieve.
Specialist-led
Every study directed by a qualified, board-certified medical specialist — not managed by project coordinators reading from a playbook.
Technology-driven
Proprietary in-house technology platform with real-time reporting, risk-based quality management, and a fully integrated eClinical suite — with physician oversight at every step.
Fixed pricing
Milestone-based billing. You pay for outcomes delivered, not hours consumed. The invoice matches the quote.
Therapeutic expertise
Deep experience where it matters most.
Unparalleled expertise in novel, challenging clinical products and less common routes of administration — the studies other CROs hesitate to take on.
What sponsors say
Trusted by biotech and pharma sponsors worldwide.
We have been using iNGENū for a Phase 1, first-in-human clinical trial of our breakthrough drug. We have been nothing but impressed by their R&D and GCP knowledge, clinical capability, project management, clinical data management, and also their very friendly way of managing, and explaining the data, clinical trial, and also how to do a clinical trial that just explained it in a very user-friendly format.
Giles Moss
Chief Executive Officer
Avata Bio
What stood out immediately was the agility. Decisions that would take weeks at a larger CRO were resolved in days, without any compromise on rigour or regulatory compliance. The team delivered at great speed, the communication was exceptional throughout, and the pricing was unmatched — significantly below every other credible option we evaluated. For a biotech operating with finite runway, that combination of quality, responsiveness, and cost-efficiency is exactly what you need.
Dr Mohit Goyal
Chief Medical Officer
Grey Matter Pharma
Frequently asked questions
Questions biotech sponsors ask us.
See what your study would cost.
Submit your study requirements and our team will be in contact within 48 hours.